ClinicalTrials.Veeva

Menu

Post Hysterectomy Pain Prevention: Pre-op Wound Infiltration With Anesthetic Protocol Versus Standard of Care

U

University of Calgary

Status and phase

Terminated
Phase 4

Conditions

Hysterectomy

Treatments

Procedure: Standard of care
Procedure: Pre-emptive wound infiltration

Study type

Interventional

Funder types

Other

Identifiers

NCT01627353
E-23700

Details and patient eligibility

About

The study is a blinded randomized clinical trial, comparing policies of high volume preemptive wound infiltration with a specific anesthetic cocktail versus standard of care (no wound infiltration and routine anesthesia) for post operative pain management after hysterectomy. Morphine use and pain will be measured during index admission, and pain will also be measured six weeks postoperatively. The study will be conducted at a single site, Rockyview General Hospital.

Enrollment

16 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women may be included if they require total abdominal hysterectomies (+/- BSO) at Rockyview hospital.

Exclusion criteria

  • have endometrial cancer,
  • require a vertical midline incision,
  • have any additional surgery planned
  • have a contraindication to morphine, Magnesium Sulfate, Dexmethasone, Lidocaine or Marcaine
  • have difficulty communicating in English

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

16 participants in 2 patient groups

Standard of Care
Active Comparator group
Description:
Current Standard of Care at Rockyview General Hospital for Post Hysterectomy Pain Prevention(no wound infiltration and routine anesthetic protocol).
Treatment:
Procedure: Standard of care
Pre-emptive wound infiltration
Experimental group
Description:
The Wound Infiltration Group will receive 100 mL 0.25% marcaine plain distributed as follows: 50 mL subcutaneously prior to skin incision along entire length of planned incision line, 50 mL subfascially prior to fascial incision, with 10 mL infiltrated directly into the rectus muscles bilaterally.
Treatment:
Procedure: Pre-emptive wound infiltration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems